|
Business Wire
|
Business Wire - The global leader in news distribution
|
|
-
Pfizer Reports Second-Quarter 2008 Results
NEW YORK--(BUSINESS WIRE)--Pfizer Inc (NYSE: PFE):
-
Pfizer to Showcase Alzheimer's Research and Pipeline at Upcoming Alzheimer's Disease Medical Meeting
NEW YORK--(BUSINESS WIRE)--Pfizer, Inc announced today that it will present nine abstracts from its Alzheimer’s disease (AD) research and development program,
-
Pfizer Fully Supports Updated PhRMA Code
NEW YORK--(BUSINESS WIRE)--Pfizer endorses the updates to the PhRMA Code on Interactions with Healthcare Professionals and will fully comply with all aspects of the Code.
-
Patients More Likely to Stay on Lipitor Than Simvastatin, a Large Observational Study Shows
NEW YORK--(BUSINESS WIRE)--Pfizer announced today that new statin users who took Lipitor® (atorvastatin calcium) were significantly more
-
Pfizer Changes Its Funding of Continuing Medical Education in the U.S.
NEW YORK--(BUSINESS WIRE)--Pfizer today announced changes in the way it supports continuing medical education (CME) initiatives for U.S. healthcare professionals.
-
FDA Approves First and Only Single-Dose Antibiotic for Dogs and Cats
NEW YORK--(BUSINESS WIRE)--Pfizer Animal Health has announced the Food and Drug Administration (FDA) has approved Convenia® (cefovecin sodium), the first and
-
Pfizer Declares a 32-Cent Third Quarter 2008 Dividend
NEW YORK--(BUSINESS WIRE)--The board of directors of Pfizer Inc today declared a 32-cent third–quarter, 2008, dividend on the company
-
Pfizer Invites Public to View and Listen to Webcast of July 23 Conference Call with Analysts
NEW YORK--(BUSINESS WIRE)--Pfizer Inc invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 11 a.m. Eastern Daylight
-
Pfizer Invites Public to View and Listen to Webcast of July 28 Pfizer Analyst and Investor Meeting at ICAD
NEW YORK--(BUSINESS WIRE)--Pfizer Inc invites investors, media, and the general public to view and listen to a webcast of a presentation by Pfizer’s
-
EyeCyte, Inc. Secures Series A Funding from Pfizer
SAN DIEGO--(BUSINESS WIRE)--EyeCyte, Inc., an early stage stem/progenitor cell-based ophthalmology research and development company based in La Jolla, California, today announced that it has
|
|
Explore the first worldwide Web 2.0 pharmaceutical news portal and 'Vote', 'Comment' or 'Submit' pharmaceutical news articles or other pharmaceutical web resources!
news
European Commission - Pharmaceuticals
US Food and Drug Administration 
